VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EGEverest Re Group, Ltd.
$373.22$15.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEGQuarterly Financials

Everest Re Group, Ltd. (EG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Everest Re Group, Ltd. (EG) quarterly income statement — complete revenue, gross profit & net income history

EG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.07B4.42B4.25B4.4B4.24B4.61B4.25B4.13B4.08B3.63B3.93B3.6B3.29B3.25B3.07B2.84B2.9B3.05B2.92B3.08B
Revenue Growth %-4.01%-4.16%0.07%6.66%3.87%27.25%8.11%14.73%24.16%11.4%27.95%26.86%13.47%6.87%5.06%-7.79%5.55%10.3%12.06%37.08%
Medical Costs & Claims2.22B2.97B3.73B3.35B3.72B5.08B3.41B3.1B3.02B3.11B3B2.65B2.63B2.46B3.26B2.51B2.4B2.42B2.84B2.14B
Medical Cost Ratio %54.5%67.13%87.61%76.11%87.71%109.99%80.22%75.1%74%85.69%76.25%73.52%79.95%75.64%106.22%88.33%82.7%79.35%97.03%69.68%
Gross Profit1.85B1.45B527M1.05B521M-461M841M1.03B1.06B519M934M953M659M793M-191M331M501M628.82M87M932.8M
Gross Margin %45.5%32.87%12.39%23.89%12.29%-9.99%19.78%24.9%26%14.31%23.75%26.48%20.05%24.36%-6.22%11.67%17.3%20.65%2.97%30.32%
Gross Profit Growth %255.28%415.34%-37.34%2.33%-50.9%-188.82%-9.96%7.87%61%-34.55%589.01%187.92%31.54%26.11%-319.54%-64.52%-7.79%131.57%-79.7%151.3%
Operating Expenses1.11B831.7M259M237M272M284M263M195M229M248M208M202M251M225M210M209M199M128.76M175M172.62M
OpEx / Revenue %27.41%18.81%6.09%5.38%6.42%6.16%6.19%4.72%5.61%6.84%5.29%5.61%7.64%6.91%6.83%7.37%6.87%4.23%5.98%5.61%
Depreciation & Amortization00000000000000000000
Combined Ratio %81.91%85.93%93.7%81.49%94.12%116.15%86.4%79.83%79.61%92.53%81.54%79.13%87.58%82.55%113.05%95.7%89.57%83.58%103.01%75.29%
Operating Income736M622M268M815M249M-745M578M833M832M271M726M751M408M568M-401M122M302M500.06M-88M760.18M
Operating Margin %18.09%14.07%6.3%18.51%5.88%-16.15%13.6%20.17%20.39%7.47%18.46%20.87%12.42%17.45%-13.05%4.3%10.43%16.42%-3.01%24.71%
Operating Income Growth %195.58%183.49%-53.63%-2.16%-70.07%-374.91%-20.39%10.92%103.92%-52.29%281.05%515.57%35.1%13.59%-355.68%-83.95%-19.06%318.83%-132.29%220.66%
EBITDA736M622M307M853M286M-711M615M869M869M306M759M783M440M595M-376M143M326M523.43M-72M775.79M
EBITDA Margin %18.09%14.07%7.22%19.37%6.75%-15.41%14.47%21.05%21.3%8.44%19.3%21.76%13.39%18.28%-12.24%5.04%11.26%17.18%-2.46%25.22%
Interest Expense36M25M38M38M38M37M38M37M37M35M34M33M32M27M25M24M24M23.36M16M15.61M
Non-Operating Income00-39M-38M-37M-34M-37M-36M-37M-35M-33M-32M-32M-27M-25M-21M-24M-23.36M-16M-15.61M
Pretax Income736M597M269M815M248M-748M577M832M832M271M725M750M408M568M-401M119M302M500.06M-88M760.18M
Pretax Margin %18.09%13.5%6.32%18.51%5.85%-16.21%13.57%20.15%20.39%7.47%18.44%20.84%12.42%17.45%-13.05%4.19%10.43%16.42%-3.01%24.71%
Income Tax83M151M14M135M39M-155M68M108M99M-532M47M80M43M72M-82M-3M4M69.36M-14M80.2M
Effective Tax Rate %11.28%25.29%5.2%16.56%15.73%20.72%11.79%12.98%11.9%-196.31%6.48%10.67%10.54%12.68%20.45%-2.52%1.32%13.87%15.91%10.55%
Net Income653M446M255M680M210M-593M509M724M733M804M678M670M365M496M-319M122M298M430.71M-73M679.98M
Net Margin %16.05%10.09%5.99%15.44%4.96%-12.85%11.97%17.53%17.97%22.17%17.24%18.62%11.11%15.24%-10.38%4.3%10.29%14.14%-2.5%22.1%
Net Income Growth %210.95%175.21%-49.9%-6.08%-71.35%-173.76%-24.93%8.06%100.82%62.1%312.54%449.18%22.48%15.16%-336.99%-82.06%-12.83%577.19%-130.03%256.24%
EPS (Diluted)16.2110.776.0916.104.90-13.8011.8016.7016.8718.5315.6416.279.3012.72-8.223.117.6710.99-1.8716.95
EPS Growth %230.82%178.04%-48.39%-3.59%-70.95%-174.47%-24.55%2.64%81.4%45.68%290.27%423.15%21.25%15.74%-339.57%-81.65%-9.98%582.61%-130.81%255.35%
EPS (Basic)16.2110.776.0916.104.90-13.7711.8016.7116.8718.5315.6416.279.3012.72-8.223.157.6711.00-1.8816.97
Diluted Shares Outstanding40.28M41.41M41.87M42.24M42.7M42.7M42.6M42.8M42.9M43.4M42.9M40.7M38.7M39M38.8M39.43M38.8M39.2M39.2M39.57M